Neuroscience Antibodies and Assays Market 2023-2027: 5-Year (2017-2021) Historic Industry Size & Analysis of 15 Vendors and 7 Countries

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- The neuroscience antibodies and assays market size is estimated to increase by USD 1,837.68 million from 2022 to 2027, with an accelerated CAGR of 9.44%, according to the recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region.

Discover some insights on market size before buying the full report. Request a free sample report.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. The Bargaining Power of Buyers & Suppliers and the Threat of New Entrants, Rivalry, and Substitutes have also been analyzed and rated between LOW-HIGH to provide a holistic view of market favorability.

Find Technavio's Exclusive Analysis of Price Sensitivity, Adoption Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria

• One of the core components of the customer landscape is price sensitivity, an analysis of which will help companies refine marketing strategies to gain a competitive advantage. 
• Another key aspect is price sensitivity drivers (purchases are undifferentiated, the purchase is a key cost to buyers, and quality is not important), which range between LOW and NEUTRAL.
• Furthermore, market adoption rates for all regions have been covered.

The neuroscience antibodies and assays market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed Below –

• Abcam plc
• Abnova Corp.
• ADx NeuroSciences NV
• Bio Rad Laboratories Inc.
• Biosensis Pty Ltd.
• BMG LABTECH GmbH
• Cell Signaling Technology Inc.
• Chemie Brunschwig AG
• Elabscience Biotechnology Inc.
• Enzo Biochem Inc.
• F. Hoffmann La Roche Ltd.
• GenScript Biotech Corp.
• Merck and Co. Inc.
• NSJ Bioreagents
• PerkinElmer Inc.
• Proteintech Group Inc.

Download a sample report 

Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparative Analysis of Segments, and Y-O-Y Growth of Neuroscience Antibodies and Assays Market

• The market is segmented by Product (Consumables and Instruments) and End-user (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, and Hospital and Diagnostic Centers).
• By Product, the consumables segment was the market's largest segment in 2022.
• The demand for neuroscience antibodies, antigens, assay kits, and reagents has significantly increased owing to the discovery of new potential drug targets, signaling molecules, and structural proteins in the brain. In addition, the rising significance of research on neuroscience processes and neurodegenerative diseases and the wide availability of antibodies, assay kits, and reagents will drive the growth of the consumables segment during the forecast period.

To procure the data - Buy report!

Increasing Incidence of Neurological Disorders is Notably Driving the Neuroscience Antibodies and Assays Market Growth

Parkinson's Disease (PD) is one of the most common neurological diseases. According to the Centers for Disease Control and Prevention (CDC), the prevalence of PD rises from 1%-4% among the population aged 60-80 years. According to The Lancet Global Health Report 2021, the burden of non-communicable neurological disorders is rising in India, mainly due to the aging population. Stroke, headache disorders, and epilepsy are the leading contributors to the burden of neurological diseases in India. Therefore, factors such as the increasing prevalence of various neurological disorders and the growing demand for treating such disorders will drive the growth of the global neuroscience antibodies and assays market during the forecast period.

Chart & Data Table on Historical Market Size (2017-2021, Historic Industry Size & Analysis of 15 Vendors and 7 Countries

The market is segmented by region (North America, Europe, Asia, and the Rest of World). An analysis of key leading countries has been included.

• North America, which holds the major share of the market, is estimated to contribute 46% to the growth of the global market during the forecast period. The rising demand for the diagnosis of neurological disorders has increased the demand for neuroscience antibodies and assays. For instance, an estimated 6.2 million Americans aged 65 years and older had Alzheimer's Disease and dementia as of March 2021. Thus, the high prevalence of neurological disorders, the growing aging population, high healthcare expenditure on treating neurological diseases, and favorable reimbursement policies for neuro-diagnostic procedures are expected to drive the regional market growth during the forecast period. 
• The increase in neurological disorders due to COVID-19 will propel R&D related to neurological symptoms, which will positively impact the market during the forecast period. Moreover, the initiation of large-scale vaccination drives by governments in Q4 of 2020 led to the lifting of lockdown restrictions and put the regional economy on track. This, in turn, led to the lifting of cross-border restrictions and the resumption of healthcare facilities, which is expected to drive the growth of the regional market during the forecast period. 

For Insights on the market dynamics & segmentations, VIEW A PDF SAMPLE!

Related Reports -

Anti-CD20 Monoclonal Antibodies (mABs) Market by Product and Geography - Forecast and Analysis 2022-2026 – size is estimated to USD 9.05 billion from 2021 to 2026, with an accelerated CAGR of 9.81%, according to the recent market study by Technavio. Furthermore, this report extensively covers market segmentations by product (oncology, neurology, and immunology) and geography (North America, Europe, Asia, and Rest of World (ROW)).  To get more exclusive research insights: VIEW SUMMARY OF THE REPORT  

Bispecific Antibodies for Cancer Market by Type and Geography - Forecast and Analysis 2022-2026 – size is estimated to increase by USD 396.56 million from 2021 to 2026, with an accelerated CAGR of 9.06%, according to the recent market study by Technavio. The increasing prevalence of cancer is one of the key factors driving the market growth. To get more exclusive research insights: VIEW SUMMARY OF THE REPORT 

Register for a free trial today and gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

What are the key data covered in this neuroscience antibodies and assays market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the neuroscience antibodies and assays market between 2023 and 2027
• Precise estimation of the size of the neuroscience antibodies and assays market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the neuroscience antibodies and assays market industry across APAC, North America, Europe, Middle East and Africa, and South America
• Thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of neuroscience antibodies and assays market vendors

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global neuroscience antibodies and assays market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global neuroscience antibodies and assays market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Consumables - Market size and forecast 2022-2027
• Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

• 6.4 Instruments - Market size and forecast 2022-2027
• Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)

• 7.4 Academic and research institutes - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)

• 7.5 Hospital and diagnostic centers - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 61: Chart on Market share by geography 2022-2027 (%)
• Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027
• Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027
• Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 104: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 106: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 107: Matrix on vendor position and classification

• 12.3 Abcam plc 
• Exhibit 108: Abcam plc - Overview
• Exhibit 109: Abcam plc - Product / Service
• Exhibit 110: Abcam plc - Key news
• Exhibit 111: Abcam plc - Key offerings

• 12.4 Abnova Corp. 
• Exhibit 112: Abnova Corp. - Overview
• Exhibit 113: Abnova Corp. - Product / Service
• Exhibit 114: Abnova Corp. - Key offerings

• 12.5 ADx NeuroSciences NV 
• Exhibit 115: ADx NeuroSciences NV - Overview
• Exhibit 116: ADx NeuroSciences NV - Product / Service
• Exhibit 117: ADx NeuroSciences NV - Key offerings

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 118: Bio Rad Laboratories Inc. - Overview
• Exhibit 119: Bio Rad Laboratories Inc. - Business segments
• Exhibit 120: Bio Rad Laboratories Inc. - Key news
• Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 122: Bio Rad Laboratories Inc. - Segment focus

• 12.7 BMG LABTECH GmbH 
• Exhibit 123: BMG LABTECH GmbH - Overview
• Exhibit 124: BMG LABTECH GmbH - Product / Service
• Exhibit 125: BMG LABTECH GmbH - Key offerings

• 12.8 Cell Signaling Technology Inc. 
• Exhibit 126: Cell Signaling Technology Inc. - Overview
• Exhibit 127: Cell Signaling Technology Inc. - Product / Service
• Exhibit 128: Cell Signaling Technology Inc. - Key offerings

• 12.9 Chemie Brunschwig AG 
• Exhibit 129: Chemie Brunschwig AG - Overview
• Exhibit 130: Chemie Brunschwig AG - Product / Service
• Exhibit 131: Chemie Brunschwig AG - Key offerings

• 12.10 Elabscience Biotechnology Inc. 
• Exhibit 132: Elabscience Biotechnology Inc. - Overview
• Exhibit 133: Elabscience Biotechnology Inc. - Product / Service
• Exhibit 134: Elabscience Biotechnology Inc. - Key offerings

• 12.11 F. Hoffmann La Roche Ltd. 
• Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus

• 12.12 GenScript Biotech Corp. 
• Exhibit 140: GenScript Biotech Corp. - Overview
• Exhibit 141: GenScript Biotech Corp. - Business segments
• Exhibit 142: GenScript Biotech Corp. - Key news
• Exhibit 143: GenScript Biotech Corp. - Key offerings
• Exhibit 144: GenScript Biotech Corp. - Segment focus

• 12.13 Merck and Co. Inc. 
• Exhibit 145: Merck and Co. Inc. - Overview
• Exhibit 146: Merck and Co. Inc. - Business segments
• Exhibit 147: Merck and Co. Inc. - Key news
• Exhibit 148: Merck and Co. Inc. - Key offerings
• Exhibit 149: Merck and Co. Inc. - Segment focus

• 12.14 PerkinElmer Inc. 
• Exhibit 150: PerkinElmer Inc. - Overview
• Exhibit 151: PerkinElmer Inc. - Business segments
• Exhibit 152: PerkinElmer Inc. - Key news
• Exhibit 153: PerkinElmer Inc. - Key offerings
• Exhibit 154: PerkinElmer Inc. - Segment focus

• 12.15 Rockland Immunochemicals Inc. 
• Exhibit 155: Rockland Immunochemicals Inc. - Overview
• Exhibit 156: Rockland Immunochemicals Inc. - Product / Service
• Exhibit 157: Rockland Immunochemicals Inc. - Key offerings

• 12.16 Santa Cruz Biotechnology Inc. 
• Exhibit 158: Santa Cruz Biotechnology Inc. - Overview
• Exhibit 159: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibit 160: Santa Cruz Biotechnology Inc. - Key offerings

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 161: Thermo Fisher Scientific Inc. - Overview
• Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 163: Thermo Fisher Scientific Inc. - Key news
• Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 168: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources

• 13.5 List of abbreviations 
• Exhibit 172: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio